Suppr超能文献

胸腔镜检查中胸膜触诊准备和直接胸膜可视化用于诊断恶性肿瘤。

Pleural Touch Preparations and Direct Visualization of the Pleura during Medical Thoracoscopy for the Diagnosis of Malignancy.

机构信息

1 Department of Pulmonary Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas.

2 Universidad del Desarrollo Clínica Alemana de Santiago, Santiago, Chile.

出版信息

Ann Am Thorac Soc. 2017 Aug;14(8):1326-1331. doi: 10.1513/AnnalsATS.201701-056OC.

Abstract

RATIONALE

During diagnostic thoracoscopy, talc pleurodesis after biopsy is appropriate if the probability of malignancy is sufficiently high. Findings on direct visual assessment of the pleura during thoracoscopy, rapid onsite evaluation (ROSE) of touch preparations (touch preps) of thoracoscopic biopsy specimens, and preoperative imaging may help predict the likelihood of malignancy; however, data on the performance of these methods are limited.

OBJECTIVES

To assess the performance of ROSE of touch preps, direct visual assessment of the pleura during thoracoscopy, and preoperative imaging in diagnosing malignancy.

METHODS

Patients who underwent ROSE of touch preps during thoracoscopy for suspected malignancy were retrospectively reviewed. Malignancy was diagnosed on the basis of final pathologic examination of pleural biopsy specimens. ROSE results were categorized as malignant, benign, or atypical cells. Visual assessment results were categorized as tumor studding present or absent. Positron emission tomography (PET) and computed tomography (CT) findings were categorized as abnormal or normal pleura. Likelihood ratios were calculated for each category of test result.

RESULTS

The study included 44 patients, 26 (59%) with a final pathologic diagnosis of malignancy. Likelihood ratios were as follows: for ROSE of touch preps: malignant, 1.97 (95% confidence interval [CI], 0.90-4.34); atypical cells, 0.69 (95% CI, 0.21-2.27); benign, 0.11 (95% CI, 0.01-0.93); for direct visual assessment: tumor studding present, 3.63 (95% CI, 1.32-9.99); tumor studding absent, 0.24 (95% CI, 0.09-0.64); for PET: abnormal pleura, 9.39 (95% CI, 1.42-62); normal pleura, 0.24 (95% CI, 0.11-0.52); and for CT: abnormal pleura, 13.15 (95% CI, 1.93-89.63); normal pleura, 0.28 (95% CI, 0.15-0.54).

CONCLUSIONS

A finding of no malignant cells on ROSE of touch preps during thoracoscopy lowers the likelihood of malignancy significantly, whereas finding of tumor studding on direct visual assessment during thoracoscopy only moderately increases the likelihood of malignancy. A positive finding on PET and/or CT increases the likelihood of malignancy significantly in a moderate-risk patient group and can be used as an adjunct to predict malignancy before pleurodesis.

摘要

背景

在诊断性胸腔镜检查中,如果恶性肿瘤的概率足够高,则在活检后进行滑石粉胸膜固定术是合适的。胸腔镜检查时对胸膜的直接可视评估、胸腔镜活检标本的即时现场评估(ROSE)、术前影像学检查可能有助于预测恶性肿瘤的可能性;然而,这些方法的性能数据有限。

目的

评估 ROSE 对触诊准备、胸腔镜检查时的直接胸膜可视评估和术前影像学在诊断恶性肿瘤中的表现。

方法

回顾性分析了在怀疑恶性肿瘤的情况下进行 ROSE 触诊准备的胸腔镜检查患者。根据胸膜活检标本的最终病理检查诊断恶性肿瘤。ROSE 结果分为恶性、良性或非典型细胞。可视评估结果分为肿瘤种植存在或不存在。正电子发射断层扫描(PET)和计算机断层扫描(CT)结果分为异常或正常胸膜。为每个测试结果类别计算了似然比。

结果

该研究纳入了 44 例患者,其中 26 例(59%)最终病理诊断为恶性肿瘤。似然比如下:ROSE 触诊准备:恶性,1.97(95%置信区间[CI],0.90-4.34);非典型细胞,0.69(95%CI,0.21-2.27);良性,0.11(95%CI,0.01-0.93);直接可视评估:肿瘤种植存在,3.63(95%CI,1.32-9.99);肿瘤种植不存在,0.24(95%CI,0.09-0.64);PET:异常胸膜,9.39(95%CI,1.42-62);正常胸膜,0.24(95%CI,0.11-0.52);CT:异常胸膜,13.15(95%CI,1.93-89.63);正常胸膜,0.28(95%CI,0.15-0.54)。

结论

胸腔镜检查时 ROSE 触诊准备中未发现恶性细胞可显著降低恶性肿瘤的可能性,而胸腔镜检查时直接可视评估中发现肿瘤种植仅适度增加恶性肿瘤的可能性。在中危患者群体中,PET 和/或 CT 的阳性发现可显著增加恶性肿瘤的可能性,并可作为预测胸膜固定术前恶性肿瘤的辅助手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验